Novo Nordisk is a standout example of a company ... Whether a business is a one-person lab or a small team at a bench, the goal should be to build a sustainable enterprise from the beginning.

To allow collaboration between the two parties and enable Asterias to progress its own clinical programmes, Novo Nordisk will sublease laboratory, manufacturing and office space within the ...

A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.

The project is part of Novo Nordisk’s digital therapeutics strategy and will first focus on creating a “virtual innovation lab” between Novo and UVA’s Center for Diabetes Technology.

She’d first heard of Wegovy, a GLP-1 made by Novo Nordisk, from a friend’s success story ... Then, another friend at work ...

Currently, Eli Lilly and Novo Nordisk dominate the diabetes and obesity care markets. BioAge Lab's weight loss candidate, aims to help patients lose weight without losing muscle mass. BioAge just ...

They first tested NNC2215 in the lab to see how it would respond in ... While it’s still early days, the study’s findings are promising. Novo Nordisk’s modified insulin holds great potential ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Morning! Today, we discuss why ...

Plus: How AI can help cancer patients avoid unnecessary chemotherapies and make it easier to understand your dental X-rays.

Besides helping to collect samples or spot butterflies for research projects — non-professionals can now conduct actual ...

Chef-turned-bioengineer Vayu Hill-Maini, an affiliate in the Biosciences Area at Lawrence Berkeley National Laboratory (Berkeley Lab), is ... the Joint BioEnergy Institute, and the Novo Nordisk ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...